Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Assets Average: 2009-2025

Historic Assets Average for Aytu Biopharma (AYTU) over the last 15 years, with Sep 2025 value amounting to $124.6 million.

  • Aytu Biopharma's Assets Average rose 6.51% to $124.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.6 million, marking a year-over-year increase of 6.51%. This contributed to the annual value of $121.1 million for FY2025, which is 4.83% down from last year.
  • Latest data reveals that Aytu Biopharma reported Assets Average of $124.6 million as of Q3 2025, which was up 0.32% from $124.2 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Assets Average ranged from a high of $268.6 million in Q2 2021 and a low of $116.0 million during Q4 2024.
  • In the last 3 years, Aytu Biopharma's Assets Average had a median value of $124.6 million in 2025 and averaged $128.0 million.
  • As far as peak fluctuations go, Aytu Biopharma's Assets Average surged by 67.50% in 2021, and later plummeted by 42.96% in 2022.
  • Over the past 5 years, Aytu Biopharma's Assets Average (Quarterly) stood at $225.8 million in 2021, then tumbled by 35.46% to $145.7 million in 2022, then declined by 9.37% to $132.1 million in 2023, then fell by 12.14% to $116.0 million in 2024, then rose by 6.51% to $124.6 million in 2025.
  • Its last three reported values are $124.6 million in Q3 2025, $124.2 million for Q2 2025, and $120.2 million during Q1 2025.